Showing results (981-990 of 1,262) with videos related to

Sort By:
Pageof 127
Frontiers in Neuroscience|April 30, 2024
Effects of movement training based on rhythmic auditory stimulation in cognitive impairment: a meta-analysis of randomized controlled clinical trialYa Nan Wang, Xiao Ni Wen, Yu Chen, et al.
Science (New York, N.Y.)|February 27, 2025
4D marmoset brain map reveals MRI and molecular signatures for onset of multiple sclerosis-like lesionsJing-Ping Lin, Alexis Brake, Maxime Donadieu, et al.
Frontiers in Human Neuroscience|March 11, 2021
The Association Between Metabolic Disturbance and Cognitive Impairments in Early-Stage SchizophreniaXing-Jie Peng, Gang-Rui Hei, Ran-Ran Li, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 1, 2021
[Selection of optimal qRT-PCR reference genes for Aconitum vilmorinianum]Li-Fang Zeng, Guo-Dong Li, Bao-Jie Wang, et al.
Chemmedchem|March 2, 2011
2-amino-3,4,5-trimethoxybenzophenones as potent tubulin polymerization inhibitorsHsun-Yueh Chuang, Jang-Yang Chang, Mei-Jung Lai, et al.
International Journal of Cardiology|February 28, 2012
Quantification of left ventricular regional myocardial function using two-dimensional speckle tracking echocardiography in healthy volunteers--a multi-center studyJing Ping Sun, Alex Pui-Wai Lee, Chengquan Wu, et al.
Journal of Medicinal Chemistry|August 6, 2004
Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agentsJing-Ping Liou, Yi-Ling Chang, Fu-Ming Kuo, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2007
Combretastatin A4-induced differential cytotoxicity and reduced metastatic ability by inhibition of AKT function in human gastric cancer cellsHeng-Liang Lin, Shih-Hwa Chiou, Chew-Wun Wu, et al.
Anticancer Research|February 9, 2013
Azatyrosinamides: novel RAS-related anticancer agentsChun-Li Wang, On Lee, Chiu-Fen Huang, et al.
European Journal of Medicinal Chemistry|July 20, 2022
Accommodation of ring C expanded deoxyvasicinone in the HDAC inhibitory pharmacophore culminates into a tractable anti-lung cancer agent and pH-responsive nanocarrierRam Sharma, Esha Chatterjee, Jacob Mathew, et al.
Pageof 127